| 摘要 |
ABSTRACT - 603414 The disclosure relates to a combination of active principles, i.e. of a xanthine oxidase inhibitor: febuxostat with one or more angiotensin II receptor antagonists belonging to the class of sartans selected from the group comprising: olmesartan medoximil, candesartan, eprosartan, irbesartan, losartan, telmisartan, valsartan or pharmaceutically acceptable salts thereof, for use in a human or veterinary therapeutic treatment, and methods for the preparation thereof. These compositions are suitable and effective in the therapeutic treatment of hypertension associated to hyperuricemia or to other disorders in the clinical context of the metabolic syndrome. |
